Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 187,335 | 65,830 | 46,177 | 43,439 | 49,778 |
| Marketable Securities | 73,008 | 95,492 | 142,472 | 173,586 | 88,676 |
| Receivables | 33,823 | N/A | N/A | N/A | N/A |
| TOTAL | $296,321 | $165,147 | $192,522 | $219,530 | $141,017 |
| Non-Current Assets | |||||
| PPE Net | 2,612 | 2,688 | 1,832 | 629 | 540 |
| Other Non-Current Assets | 1,283 | 1,283 | 1,281 | 1,281 | 1,383 |
| TOTAL | $3,895 | $3,971 | $3,113 | $1,910 | $1,923 |
| Total Assets | $300,216 | $169,118 | $195,635 | $221,440 | $142,940 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,039 | 8,524 | 5,143 | 2,415 | 2,313 |
| Accrued Expenses | 30,261 | 17,615 | 15,789 | 10,994 | 9,555 |
| TOTAL | $114,268 | $26,139 | $20,932 | $13,409 | $11,868 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 81,968 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 27 | 7 | 9 | 12 | 5 |
| TOTAL | $117,828 | $42,269 | $41,415 | $40,269 | $74 |
| Total Liabilities | $232,096 | $68,408 | $62,347 | $53,678 | $11,942 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,830 | 38,324 | 38,012 | 37,977 | 37,943 |
| Retained earnings | -297,136 | -259,274 | -222,966 | -187,187 | -161,389 |
| Other shareholders' equity | -42 | -7 | 37 | -189 | -396 |
| TOTAL | $68,120 | $100,710 | $133,288 | $167,762 | $130,998 |
| Total Liabilities And Equity | $300,216 | $169,118 | $195,635 | $221,440 | $142,940 |